Background: In infected incisional ventral hernias (IVHs), the use of a synthetic non-absorbable mesh is not recommended and biological meshes hold promise. However, the level of evidence for their safety and efficacy remains low.

Methods: The SIMBIOSE trial is a multicenter, phase III, randomized, controlled trial comparing the use of a biological mesh versus traditional wound care in patients with an IVH. The primary end point is 6-month infectious and/or wound morbidity. Secondary end points are wound infection and recurrent hernia rates, post-operative pain, quality of life, time to heal, reoperation need, impact of the cross-linked mesh structure, and a medico-economic evaluation. One hundred patients need to be included.

Results: The main results expected with biological mesh use are a significant decrease of post-operative morbidity, hernia recurrence, time to heal, and costs with an improved quality of life.

Conclusions: For the first time, the impact of biological meshes in the treatment of IVHs will be evaluated in an academic, randomized, phase III trial to provide scientific evidence (NCT01594450).

Trial Registration: ClinicalTrial.gov, NCT01594450.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675420PMC
http://dx.doi.org/10.1186/1745-6215-14-131DOI Listing

Publication Analysis

Top Keywords

biological mesh
12
mesh versus
8
wound care
8
infected incisional
8
incisional ventral
8
ventral hernias
8
controlled trial
8
biological meshes
8
phase iii
8
time heal
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!